Prot #PCCTC #: c17‐191: CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone, A Phase II Study of Carboplatin, Cabazitaxel and Abiraterone in Metastatic Castration Sensitive Prostate Cancer with and without DNA Repair Mutations

Project: Research project

Project Details

StatusFinished
Effective start/end date2/28/20 → 2/28/23

Funding

  • Prostate Cancer Clinical Trials Consortium, LLC (PCCTC #: c17‐191)
  • Genzyme Corporation (PCCTC #: c17‐191)